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ABSTRACT
Objective: The aim of this study was to estimate the
frequency of falls in people with Huntington’s disease
(HD) and make a preliminary assessment of tools
appropriate for assessing the risk of falling.
Design: Observational study.
Setting: Hospital clinic.
Subjects: 24 people with HD.
Main measures: Balance was assessed using the Berg
Balance Scale (BBS) and Timed ‘‘Up & Go’’ (TUG) test.
Walking speed over 10 m was recorded. Long-term
monitoring of walking activity was undertaken. Unified
Huntington Disease Rating Scale (UHDRS) motor,
Functional Assessment Scale (FAS), Independence Scale
(IS) and Total Functional Capacity (TFC) scores were
obtained as well as data about falls and stumbles.
Differences between ‘‘recurrent fallers’’ (>2 falls/year)
and ‘‘non-fallers’’ ( 1 fall/year) for the range of outcome
measures were investigated and probabilities calculated.
Results: Mean (SD) age (years) of people with HD
(n = 24) tested was 56.6 (11.7) and BMI (kg/m2) 24.7
(5.5). Median (range) UHDRS motor scores were 48 (28–
80). Ten (41.6%) patients reported (1 fall and 14
(58.3%) >2 falls in the previous 12 months. Recurrent
fallers walked less (p,0.01) and slower than non-fallers.
Their balance (BBS) (p,0.01) was worse and TUG scores
were higher (p,0.01). People with HD had increased risk
of falls if TUG scores were >14 s or BBS scores (40.
Conclusion: A high proportion of HD patients have
recurrent falls, and the BBS and TUG appear to be useful
in falls risk assessment.
Huntington disease (HD) results in progressive loss
of functional abilities. Despite reports highlighting
falls-related injuries and associated balance pro-
blems,1–3 there is no systematic research on falling
and its risk factors in HD in the community.
Formal assessment of falls is not part of the
standard validated assessment protocols in wide-
spread use.
The standard assessment tool for HD is the
Unified Huntington Disease Rating Scale
(UHDRS).4 The UHDRS comprises semiquantita-
tive clinical scales to assess motor function,
cognitive function, behavioural abnormalities and
functional capacity. UHDRS motor scores have
been found to be sensitive to change over time5
with higher scores indicating greater impairment
for the motor assessment. The UHDRS functional
scale comprises three components (functional
assessment scale (FAS), the independence scale
(IS), and the Total Functional Capacity (TFC)).
Although UHDRS scores can be considered indica-
tors of impairment and functional loss, their value
in predicting likelihood of falls is unknown.
The Activities-Specific Balance Confidence Scale
(ABC)6 is a self-administered questionnaire used to
assess fear of falling in older people and has
discriminant ability to identify fallers from non-
fallers and those who avoid activity due to fear of
falling.7 Additionally clinical measurements of
mobility and balance, such as the Timed Up and
Go Test (TUG)8 and the Berg Balance Scale (BBS),9
are known to relate to falls’ risk in other condi-
tions.10 The TUG and the BBS have been reported
to be useful in single cases of people with HD1 but
have not been formally validated for this use.
Although anecdote suggests that people with HD
are at risk of falls and do fall, falls’ rate does not
appear to have been investigated in depth. We aim
here to assess fall prevalence and consider the
above-mentioned potential measures of increased
fall risk in the HD population.
METHODS
Subjects
Patients with manifest HD attending the Cardiff
HD clinic between December 2006 and
November 2007 were offered participation in
the study in accordance with local research ethics
committee permissions (06/WSE03/70). All sub-
jects provided informed consent prior to partici-
pation. Inclusion criteria were a genetically
confirmed diagnosis of HD, age over 18, capacity
for informed consent, no major concurrent
psychiatric illness, presentation with motor signs
and a score of 4 on the UHDRS motor diagnostic
confidence rating.
Demographic data including age (years), and
body mass index (BMI) (kg/m2) and current
medication were obtained. Scores on the motor
section of the Unified Huntington Disease Rating
Scale (UHDRS motor), the Total Functional
Capacity (TFC), the Functional Assessment Scale
(FAS) and the Independence Scale were recorded.
Balance and walking
Patients were assessed using the Berg Balance Scale
(BBS) (maximum score 56 indicating good balance)
and the ‘‘Timed Up & Go’’ (TUG) test. The
modified Activities-Specific Balance Confidence
(ABC-UK) Scale provided an estimate of balance
confidence. Self-selected walking speed over 10 m
was recorded in an indoor corridor. Stride length
was also calculated. Long-term walking activity
was recorded using using the Step Watch Step
Activity Monitor (SAM) (Cymatech, Seattle,
Washington) worn for seven consecutive 24 h
periods. This device and protocol has been used
previously in patients with chronic neurological
disorders.11 Indices extracted were mean daily 24 h
step count and highest average step count
sustained over any continuous 60 min period
(sustained activity).
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Falls and stumbles
Data were collected for falls and stumbles in the previous
12 months using a questionnaire.12 The questionnaire was
completed by the patient with assistance from their main carer.
Participants were categorised as recurrent fallers if they reported
>2 falls over the previous 12 months. If patients reported (1
fall, they were not considered to be recurrent fallers.13
Data analysis
Descriptive statistics were used to quantify falls and scores on
outcome measures. Independent t tests, Mann–Whitney U tests
and x2 tests were used where relevant to detect differences on
outcome measures according to whether a person was a
recurrent faller or non-faller. Logistic regression was used to
plot the probability of falling for the each of the separate
continuous falls risk outcome measures (ie, the BBS and the
TUG). The alpha level was set at 0.05. The Statistical Package
for the Social Sciences (SPSS) Version 12 (SPSS, Chicago) was
used for all data analysis and Minitab Version 14 for graphing.
Sample size
A priori sample size calculations were conducted using
WINPEPI software:14 20 subjects were sufficient to detect a
standardised difference in outcome measures of 1.25 between
recurrent fallers and non-fallers (independent t test).
RESULTS
Twenty-four people with HD were recruited. Demographic data
are presented in table 1. The most common medications
prescribed for this group were antichoreic medication (41.6%
of patients), benzodiazepines (16.6% of patients) and those
with an antidepressant main action (50% of patients).
Five (20.8%) people reported no falls in the previous
12 months, and five (20.8%) reported only one fall: thus 10
were classified ‘‘non-fallers.’’ Fourteen (58.3%) reported falling
twice or more in the previous 12 months (classified as recurrent
fallers). Of the recurrent fallers, 61.6% were also stumbling
frequently, while in the non-fallers, 50% reported stumbling on
a regular basis. Table 1 shows the outcome scores for the whole
group and non-fallers and recurrent fallers subgroups.
There were no differences in age, BMI or gender between
those who were classified as recurrent fallers and those classified
as non-fallers. There were no clear differences in frequency of
prescription of the anti-choreic medication between fallers (6/
14) and non-fallers (4/10) or bensodiasepines in the fallers (3/14)
compared with the non-fallers (1/10) although the numbers
were too small to analyse these data statistically.
Logistic regression identified the continuous variables of TUG
(s) and BBS score as significant predictors of falls. The TUG and
BBS were not entered into a combined logistic regression model
due to the high correlations between the measures. Predicted
probabilities for falling plotted against the continuous variables
identified a classification cut-off for increased risk of falls if
TUG scores were >14 s or BBS scores (40. Figure 1 shows the
plots of the probabilities obtained for falls for the TUG and BBS
scores against the continuous TUG and BBS scores.
DISCUSSION
This study confirms that people with manifest HD do fall
regularly. Only 20.8% of people did not report any falls in the
previous 12 months. Fallers took fewer steps and walked more
slowly than non-fallers, and their balance (BBS and TUG scores)
and balance confidence (ABC-UK) were worse. Scores for non-
fallers (n = 10) and recurrent fallers (n = 14) were different for
the IS and FAS but not for the other UHDRS-related clinical
scores (including UHDRS motor). This study was not specifi-
cally powered to detect differences in the UHDRS motor scores.
The TUG and BBS scores both predicted probability of falling
and may therefore be considered for use in people with HD. The
susceptibility of the TUG to cognitive impairment may however
limit its applicability in HD; this test needs a clear understanding
of the instructions as well as an interaction between patient,
assessor and environmental setting.15 The BBS, developed
primarily to evaluate balance in elderly people and people with
stroke, may be more robust in those with cognitive impairment.
Recurrent fallers were less active than non-fallers (step count
and sustained step counts) and less independent. Both step
count and sustained step counts were statistically significantly
different between fallers and non-fallers. While a daily step
count recording may mistakenly register chorea as steps,
therefore inflating the step count of subjects with worse
chorea, the sustained walking step counts should be more
robust. It is unclear whether the reduction in physical activity is
related more to perceived balance and confidence or is a direct
result of the motor impairments seen in HD.
The importance of objective recordings is also an issue in the
assessment of falls rate.
The extent to which carer bias may have influenced falls’
reporting is unclear and emphasises the need for alternative
methods of evaluation. Self-reported questionnaires are subject
to bias, and failure to recall an injury is high using self report;
calendar recording of falls events would be more accurate in
recording falls and injuries.16 17 While falls and stumbles do occur
in healthy subjects,12 it would be unusual for healthy people to
report recurrent falls. We attempted to minimise report failure
by careful involvement of carers in questionnaire completion,
but one might anticipate potential under-reporting. Such under-
reporting limits the usefulness of the dichotomised outcome (1
or >2 falls except that the latter probably indicates a group
falling more often. Reliance on patient/carer recall or recording
of falls could be objectively augmented by techniques such as
automated event recording18 over prolonged periods (weeks).
Figure 1 Score on continuous outcome measures (Timed ‘‘Up & Go’’
(TUG) and Berg Balance Scale (BBS)) and related probability of falls.
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Falls, injury and loss of independent ambulation are often
factors that precipitate admission to nursing homes,3 and falls,
risk of falls and basic falls management advice19 should also be
considered a priority in people with HD. Falling in HD is likely
to be multifactorial in origin,20 and factors such as home
environment, medication and cognitive status also require
further investigation. Reduced step count and physical activity
as well as reduced scores on functional capacity and indepen-
dence scales and reduced balance confidence may be indicative
of a person at risk of falls. The BBS as well as the TUG also have
potential as falls risk outcome measures in HD.
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Table 1 Comparison of scores for all outcomes for the whole group and for the subgroups (non-fallers vs recurrent fallers)
Outcome
Whole group Subgroup: non-faller Subgroup: recurrent faller
Mean (SD) age 56.6 (11.7), BMI
24.7(5.5); 16 males: eight females
Mean (SD) age 55.2 (6.8), BMI 22.9
(4.3); six males: four females
Mean (SD) age 57.6 (14.4), BMI 25.9 (6.1); 10
males: four females
Unified Huntington’s Disease Rating
Scale motor score{
48 (28 to 80) 43 (28 to 72) 52 (36 to 68) (approximate 95% CI of difference
219.7 to 3.9)
Total functional capacity{ 7 (3 to 11) 8 (4 to 11) 5.5 (3 to 9) (approximate 95% CI of difference
20.03 to 3.9)
Functional Assessment Scale{ 18 (7 to 25) 21 (11 to 25) 14 (9 to 22)* (approximate 95% CI of difference
1.5 to 10.1)
Independence scale{ 77.5 (50 to 95) 81.9 (10.7) 67. 5 (10.1)** (95% CI of difference 4.5 to 24.3)
Daily right step count{ 4978 (2185) 6729 (1494) 3853 (1796)** (95% CI difference 1376 to
4373 steps)
Steps/minute sustained for 60 min{ 24.4 (9.4) 30 (6.6) 20 (9)* (95% CI of difference 2 to
17 steps/min)
Gait speed (m/s){ 0.88 (0.24) 1.03 (0.2) 0.8 (0.2)* (95% CI of difference 0.05 to
0.45 m/s)
Activities-Specific Balance
Confidence Scale-UK (%){
60.7 (27.4) 77.5 (13.9) 47.9 (28.6)** (95% CI of difference 10.6 to
48.6%)
Berg Balance Scale{ 41 (18 to 54) 45 (33 to 54) 38 (18 to 48)** (approximate 95% CI of
difference 2.3 to 17.8)
‘‘Timed Up & Go’’ test (s){ 14.2 (7.7 to 52.6) 12.6 (7.7 to 16.6) 15.6 (7.7 to 52.6)** (approximate 95% CI of
difference 0.07 to 15.4 s)
Recurrent fallers and non-fallers were assessed for between-group differences.
**Significant difference between fallers and non-fallers at the 0.01 level (two-tailed).
*Significant difference at the 0.05 level (two-tailed).
{Median (range) data are presented.
{Mean (SD) data are presented.
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